home / stock / sphs / sphs quote
Last: | $ |
---|---|
Change Percent: | 2.40% |
Open: | $0.74 |
Close: | $0.6899 |
High: | $0.74 |
Low: | $0.6765 |
Volume: | 78,918 |
Last Trade Date Time: | 02/12/2020 04:49:52 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.74 | $0.6899 | $0.74 | $0.6765 | 78,918 | 02-12-2020 |
$ | $0.70 | $0.6737 | $0.74 | $0.6503 | 108,955 | 02-11-2020 |
$ | $0.75 | $0.7198 | $0.81076 | $0.70 | 247,443 | 02-10-2020 |
$ | $0.81 | $0.755 | $0.81 | $0.74 | 119,839 | 02-07-2020 |
$ | $0.80 | $0.7718 | $0.83 | $0.7718 | 72,095 | 02-06-2020 |
$ | $0.7784 | $0.82635 | $0.84 | $0.7784 | 99,283 | 02-05-2020 |
$ | $0.8001 | $0.7973 | $0.87 | $0.7911 | 128,857 | 02-04-2020 |
$ | $0.8029 | $0.7776 | $0.82 | $0.765 | 148,760 | 02-03-2020 |
$ | $0.82 | $0.80 | $0.8569 | $0.7902 | 201,202 | 01-31-2020 |
$ | $0.8334 | $0.81 | $0.89 | $0.77 | 666,359 | 01-30-2020 |
$ | $0.7985 | $0.8302 | $0.844 | $0.733421 | 178,478 | 01-29-2020 |
$ | $0.8163 | $0.7998 | $0.844 | $0.7501 | 301,189 | 01-28-2020 |
$ | $0.72 | $0.855 | $0.88 | $0.67 | 729,475 | 01-27-2020 |
$ | $0.7137 | $0.6735 | $0.75 | $0.66 | 266,843 | 01-24-2020 |
$ | $0.79 | $0.70 | $0.79 | $0.69 | 361,988 | 01-23-2020 |
$ | $0.87 | $0.79 | $0.87 | $0.726 | 560,995 | 01-22-2020 |
$ | $0.67 | $0.88 | $0.88 | $0.6601 | 1,649,654 | 01-21-2020 |
$ | $0.645 | $0.6558 | $0.70 | $0.64 | 386,696 | 01-20-2020 |
$ | $0.645 | $0.6558 | $0.70 | $0.64 | 386,254 | 01-17-2020 |
$ | $0.63 | $0.6613 | $0.674 | $0.60 | 161,274 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO and VANCOUVER, British Columbia , May 18, 2020 /PRNewswire/ -- Sophiris Bio Inc. (OTCQB: SPHS) (the "Company" or "Sophiris"), today announced that its board of directors has formally approved an immediate shutdown of the operations of the Company. The Compa...
SAN DIEGO and VANCOUVER, British Columbia, March 10, 2020 (GLOBE NEWSWIRE) -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the tre...
SAN DIEGO and VANCOUVER, British Columbia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Sophiris Bio Inc. (NASDAQ: SPHS), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseas...